s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
4
Cherington Charles: Statement of changes in beneficial ownership of securities
Filed
Tuesday, February 17, 2026
Period
Feb 10, 2026
Accession number
0001104659-26-016680
Documents
OWNERSHIP DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header